Radiomics based on biparametric MRI for the detection of significant residual prostate cancer after androgen deprivation therapy: using whole-mount histopathology as reference standard-Reference-Cited by-同舟云学术

Radiomics based on biparametric MRI for the detection of significant residual prostate cancer after androgen deprivation therapy: using whole-mount histopathology as reference standard

Published:2023 Issue:1 Volume:25 Page:86
ISSN:1008-682X
Container-title:Asian Journal of Andrology
language:en
Short-container-title:Asian J Androl

Author:

Zhou Liang-Ping,Liu Xiao-Hang,Chen Zhang-Zhe,Gu Wei-Jie,Zhou Bing-Ni,Liu Wei,Gan Hua-Lei,Zhang Yong

Publisher

Medknow

Subject

Urology,General Medicine

Reference26 articles.

1. Global incidence of prostate cancer in developing and developed countries with changing age structures;Teoh;PLoS One,2019

2. Prostate cancer in East Asia: evolving trend over the last decade;Zhu;Asian J Androl,2015

3. Stage-specific incidence rates and trends of prostate cancer by age, race, and ethnicity, United States, 2004-2014;Li;Ann Epidemiol,2018

4. Current treatment strategies for advanced prostate cancer;Komura;Int J Urol,2018

5. PSA and beyond: alternative prostate cancer biomarkers;Saini;Cell Oncol (Dordr),2016

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancing Personalized Prostate Cancer Therapy Through Hormonal Treatment: Promising Findings;2024 IEEE International Symposium on Biomedical Imaging (ISBI);2024-05-27

2. Diagnostic efficacy and interobserver agreement among readers with variable experience of the Prostate Imaging for Recurrence Reporting system with whole-mount histology after androgen deprivation therapy as a reference;Quantitative Imaging in Medicine and Surgery;2024-04

3. Association of Pathological Features and Multiparametric MRI‐Based Radiomics With TP53‐Mutated Prostate Cancer;Journal of Magnetic Resonance Imaging;2023-12-28